1.65 USD
▼-0.20-10.81%
盘后 1.40 -15.15%
2026-11-20
市值
$3.00M
市盈率
—
EPS
-33.31
股息率
—
52 周区间
1.63 – 80.70
成交量
71.80K
Beta
-1.05
目标价
—
52W 低 1.6352W 高 80.70
价格走势
公司简介
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cance...